IE42002L - Antigens-modified polypeptides - Google Patents

Antigens-modified polypeptides

Info

Publication number
IE42002L
IE42002L IE740967A IE96774A IE42002L IE 42002 L IE42002 L IE 42002L IE 740967 A IE740967 A IE 740967A IE 96774 A IE96774 A IE 96774A IE 42002 L IE42002 L IE 42002L
Authority
IE
Ireland
Prior art keywords
human
peptide
antigens
modified polypeptides
active
Prior art date
Application number
IE740967A
Other versions
IE42002B1 (en
Original Assignee
Univ Ohio State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ohio State filed Critical Univ Ohio State
Publication of IE42002L publication Critical patent/IE42002L/en
Publication of IE42002B1 publication Critical patent/IE42002B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The composition has an active immunising action against reproduction in humans and mammals. It contains as active component a biologically determinant peptide of one of the protein-reproducing hormones follicle-stimulating hormone (FSH), luteinising hormone (LH), human placental lactogen (HPL), human prolactin or human chorionic gonadotropin (HCG). The peptide is modified to an artificial antigen in an immunochemically known way. [GB1473601A]
IE967/74A 1973-05-07 1974-05-07 Antigen modification of polypeptides IE42002B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
US40682173A 1973-10-16 1973-10-16

Publications (2)

Publication Number Publication Date
IE42002L true IE42002L (en) 1974-11-07
IE42002B1 IE42002B1 (en) 1980-05-21

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
IE967/74A IE42002B1 (en) 1973-05-07 1974-05-07 Antigen modification of polypeptides

Country Status (17)

Country Link
JP (1) JPS623128B2 (en)
AT (1) AT356263B (en)
AU (1) AU524925B2 (en)
CA (1) CA1057742A (en)
CH (1) CH622426A5 (en)
DD (1) DD113919A5 (en)
DE (1) DE2421943A1 (en)
FR (1) FR2228477B1 (en)
GB (1) GB1473601A (en)
HK (1) HK41280A (en)
IE (1) IE42002B1 (en)
IL (1) IL44779A (en)
MY (1) MY8100128A (en)
NL (1) NL7406098A (en)
NZ (1) NZ174192A (en)
PL (1) PL97318B1 (en)
SE (1) SE7406096L (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
FR2319379A1 (en) * 1975-07-29 1977-02-25 All India Inst Medical Scie Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium)
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (en) * 1976-09-16 1981-08-11
US4096237A (en) * 1977-03-14 1978-06-20 Hoffmann-La Roche Inc. Immunoassay for β-endorphin
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine
FR2832066A1 (en) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (en) * 1963-07-17 1968-12-12 Behringwerke Ag Process for the production of artificial antigens
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Also Published As

Publication number Publication date
JPS623128B2 (en) 1987-01-23
DE2421943A1 (en) 1974-11-28
IL44779A (en) 1977-10-31
MY8100128A (en) 1981-12-31
GB1473601A (en) 1977-05-18
CA1057742A (en) 1979-07-03
CH622426A5 (en) 1981-04-15
NL7406098A (en) 1974-11-11
FR2228477A1 (en) 1974-12-06
HK41280A (en) 1980-08-15
DE2421943C2 (en) 1989-10-26
FR2228477B1 (en) 1977-07-01
NZ174192A (en) 1985-02-28
ATA377074A (en) 1979-09-15
AU524925B2 (en) 1982-10-14
IE42002B1 (en) 1980-05-21
DD113919A5 (en) 1975-07-05
JPS5069221A (en) 1975-06-10
PL97318B1 (en) 1978-02-28
AU6869574A (en) 1975-11-13
SE7406096L (en) 1975-01-31
IL44779A0 (en) 1974-07-31
AT356263B (en) 1980-04-25

Similar Documents

Publication Publication Date Title
Gay et al. Patterns of gonadotrophin secretion associated with ovulation
Schally et al. Edward T. Tyler Prize Oration: LH-releasing hormone and its analogues: recent basic and clinical investigations
Wehrenberg et al. Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats
Borgeat et al. Inhibition of adenosine 3′, 5′-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone
IE42002L (en) Antigens-modified polypeptides
McCormack et al. The effect of luteinizing hormone releasing hormone (LHRH) antiserum administrationon gonadotropin secretion in the rhesus monkey
KR850007559A (en) Implantable Formulations of Regulatory Peptides
CA2057860A1 (en) Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB1460522A (en) Process for the manufacture of antige-coated or antigen-coated or antigen-protein conjugate-coated erythrocytes
HUP0100681A1 (en) Disulfide cross-linked glycoprotein hormone analogs, their preparation and use
Taya et al. Changes in FSH, LH and prolactin secretion during estrous cycle in rats
GOSS et al. Immunologic differentiation of luteinizing hormone and human chorionic gonadotropin in compounds of high purity
JPS5240062A (en) Process for production of semiconductor devices
EP0282343A3 (en) Method to stimulate the immune response to specific antigens
CA2010256A1 (en) Protein anti-cancer agent
Arimura et al. Release of luteinizing hormone by synthetic LH-releasing hormone in the ewe and ram
Fraser et al. Effect of active immunization to luteinizing hormone releasing hormone on gonadotrophin levels in ovariectomized rats
JPS54126723A (en) Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
Dupont et al. Conversion of big pancreatic somatostatin without peptide bond cleavage into somatostatin tetradecapeptide
JPS5251099A (en) Manufacture of fermented seasoning agent
Eddy et al. Amphibian metamorphosis: the role of thyrotropin-like hormone
EP0132488A3 (en) Rat antibody to human chorionic gonadotropin
WO2001024765A3 (en) Antigenic modification of polypeptides
JPS5411682A (en) Semiconductor device
PARLOW et al. A highly immunoreactive peptide fragment of human luteinizing hormone alpha subunit, discerned with a new,“sequence-specific” radioimmunoassay